In the immediate aftermath of the Obamacare rollout, pharma and healthcare M&A fell. Now, however, it's back up, on deals like Monday morning's Covidien - Medtronic announcement, a merger valued at $43 billion. While some deals in the healthcare industry are being guided by synergies, other, like Monday's MergerTalk deal, are being guided by strategy. Medtronic needs to relocate its Minnesota tax base to Ireland, where Covidien is based, in order to save on a hefty U.S. tax bill. Medtronic isn't the only one: Pfizer attempted to acquire AstraZeneca, for the same reasons. The Deal's Jon Marino and Sarah Pringle have details from Wall Street.

More from Video

Tax Tip: Don't Put Your 2017 Tax Return Away -- Yet! (Watch!)

Tax Tip: Don't Put Your 2017 Tax Return Away -- Yet! (Watch!)

The CEO of Wall Street Disruptor Symphony Reacts to Tuesday's Market Declines

The CEO of Wall Street Disruptor Symphony Reacts to Tuesday's Market Declines

60 Seconds: What is the Yield Curve and Why is it Screaming Recession?

60 Seconds: What is the Yield Curve and Why is it Screaming Recession?

Coke Has Figured Out How to Stay Relevant (Watch)

Coke Has Figured Out How to Stay Relevant (Watch)

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash